Schroder Investment Management Group Cytokinetics Inc Transaction History
Schroder Investment Management Group
- $112 Billion
- Q2 2025
A detailed history of Schroder Investment Management Group transactions in Cytokinetics Inc stock. As of the latest transaction made, Schroder Investment Management Group holds 310,891 shares of CYTK stock, worth $20.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
310,891
Previous 345,598
10.04%
Holding current value
$20.7 Million
Previous $13.9 Million
26.05%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding CYTK
# of Institutions
390Shares Held
130MCall Options Held
3.61MPut Options Held
1.13M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1.17 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$976 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$788 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$521 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$424 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.26B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...